Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement

Longitudinal monitoring of patients with fibrotic interstitial lung disease (ILD) is essential to identifying disease progression and guiding management decisions. There are no evidence-based clinical practice guidelines to inform decision-making for the appropriate components and frequency of monitoring patients with fibrotic ILD. This position statement summarizes the key components of long-term monitoring of fibrotic ILD, including the appropriate frequency of monitoring, specific symptoms and comorbidities to consider, and the objective testing that should be routinely performed. Key messages based on scientific literature review and consensus from a panel of ILD experts are provided to guide clinical practice.